altRx vs IVIM Health: Price vs Clinical Satisfaction Compared

Comparing altRx vs IVIM Health quickly: altRx emphasizes affordability with compounded semaglutide starting at $89/month and 100% online visits, while IVIM Health emphasizes clinician-guided optimization and strong third-party ratings. Early verdict: choose altRx for lowest advertised monthly pricing; choose IVIM Health for its structured GLP-1 ID protocol and dual 4.9-star ratings.

See altRx pricing and start for $89/mo

Key differences at a glance for altRx vs IVIM Health

This comparison focuses on five supported differences: starting price and pricing structure, program model and protocol, third-party ratings and published outcomes, compounded medication regulatory notes, and membership/fees and promotions.

1) Starting price and pricing structure

altRx lists compounded semaglutide starting at $89/month and tirzepatide at $149/month, with multi-month plans lowering per-month cost. IVIM Health advertises semaglutide at $75/month on some offers but lists ongoing pricing that includes program fees and a published ongoing rate of $174/month after introductory pricing. altRx markets a consistent “same price every month” message during its limited offer; IVIM highlights a free month membership code GIFT75 and a no-obligation free consultation valued at $75.

2) Program model and clinical approach

altRx: 100% online medical visits, a 2-minute quiz to start, and a care team that provides ongoing clinician-guided support. If prescribed, medications ship from licensed pharmacies and typical processing is approximately 4–5 business days. IVIM Health: clinician-guided GLP-1 ID protocol with weekly dose adjustments and a structured optimization approach the company says can accelerate outcomes; the 40% faster statement is a proprietary protocol claim and not an independent head-to-head result.

Start altRx’s 2-minute quiz and online visit

3) Third-party ratings, published data, and trust signals

IVIM Health reports a 4.9-star rating on both Google and Trustpilot and cites retrospective observational studies and internal published analyses tied to its GLP-1 ID protocol. altRx’s materials emphasize affordability and accessibility but do not present the same dual third-party rating evidence in the supplied source.

4) Compounding and regulatory notes

Both providers prescribe compounded GLP-1 medications. altRx’s materials explicitly state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. IVIM Health likewise notes that compounded drugs are not FDA-approved and have not undergone FDA review; IVIM also clarifies that its published outcomes include data from branded and compounded formulations and that results may vary.

5) Memberships, fees, shipping, and availability

altRx emphasizes no membership, no insurance required, no hidden fees, cancel anytime, free and discreet 2-day delivery, and availability across all 50 U.S. states with provider availability varying by state. IVIM offers a no-obligation free consultation, a free month code, and mentions a program fee (for example a +$74.99/mo program fee shown alongside some pricing) and that medications are prepared by independent, licensed compounding pharmacies; availability is not universal in all states.

What this means for you

altRx vs IVIM Health boils down to priorities. If your primary concern is the lowest advertised monthly price and a fully remote sign-up and delivery model, altRx presents a limited offer with compounded semaglutide at $89/month and an emphasis on all-inclusive monthly pricing. If you prioritize third-party satisfaction signals and a structured clinician-led protocol with published observational analyses, IVIM Health highlights a dual 4.9-star rating and its GLP-1 ID protocol and offers a free month via code GIFT75 plus a no-obligation free consultation.

Choose based on the evidence

Choose altRx if you want the lowest advertised starting price and a 100% online, no-membership, cancel-anytime model with free 2-day delivery, understanding the medication is compounded and not FDA-approved. Choose IVIM Health if you value strong third-party ratings, a clinician-guided GLP-1 ID protocol with published observational data and you want to use the GIFT75 free-month code and free consultation to trial the program. Both platforms prescribe compounded medications and note that compounded products are not FDA-reviewed; availability and prescribing depend on clinician review and state laws.